{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:32:57Z","timestamp":1761989577669},"reference-count":63,"publisher":"Radiation Research Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiation Research"],"published-print":{"date-parts":[[2021,1,29]]},"DOI":"10.1667\/rade-20-00145.1","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T11:15:19Z","timestamp":1617189319000},"source":"Crossref","is-referenced-by-count":11,"title":["Low Dose of Trichostatin A Improves Radiation Resistance by Activating Akt\/Nrf2-Dependent Antioxidation Pathway in Cancer Cells"],"prefix":"10.1667","volume":"195","author":[{"given":"Fengqiu","family":"Zhang","sequence":"first","affiliation":[{"name":"CAS Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Institute of Intelligent Machines, HFIPS, Chinese Academy of Sciences, Hefei, 230031, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changsheng","family":"Shao","sequence":"additional","affiliation":[{"name":"CAS Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Institute of Intelligent Machines, HFIPS, Chinese Academy of Sciences, Hefei, 230031, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu","family":"Chen","sequence":"additional","affiliation":[{"name":"CAS Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Institute of Intelligent Machines, HFIPS, Chinese Academy of Sciences, Hefei, 230031, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalin","family":"Li","sequence":"additional","affiliation":[{"name":"Henan Key Laboratory of Ion-beam Bioengineering, School of Physics, Zhengzhou University, Zhengzhou, 450052, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xumiao","family":"Jing","sequence":"additional","affiliation":[{"name":"Henan Key Laboratory of Ion-beam Bioengineering, School of Physics, Zhengzhou University, Zhengzhou, 450052, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Huang","sequence":"additional","affiliation":[{"name":"CAS Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Institute of Intelligent Machines, HFIPS, Chinese Academy of Sciences, Hefei, 230031, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1243","reference":[{"key":"27","doi-asserted-by":"crossref","unstructured":"R Iyer and BE Lehnert \"Mutat Res.\" 503, \"Low dose, low-LET ionizing radiation-induced radioadaptation and associated early responses in unirradiated cells.\" 1 (2002)","DOI":"10.1016\/S0027-5107(02)00068-4"},{"key":"1","doi-asserted-by":"crossref","unstructured":"DG Kirsch, PM Santiago, DT Emmanuelle, et al. \"Science.\" 327, \"p53 controls radiation-induced gastrointestinal syndrome in mice independent of apoptosis.\" 593 (2010)","DOI":"10.1126\/science.1166202"},{"key":"2","doi-asserted-by":"crossref","unstructured":"MS Wason, J Colon, S Das, et al. \"Nanomedicine.\" 9, \"Sensitization of pancreatic cancer cells to radiation by cerium oxide nanoparticle-induced ROS production.\" 558 (2013)","DOI":"10.1016\/j.nano.2012.10.010"},{"key":"3","doi-asserted-by":"crossref","unstructured":"YR Lawrence, XA Li, I El Naqa, et al. \"Int J Radiat Oncol Biol Phys.\" 76, \"Radiation dose-volume effects in the brain.\" S20 (2010)","DOI":"10.1016\/j.ijrobp.2009.02.091"},{"key":"4","doi-asserted-by":"crossref","unstructured":"RW Johnstone and JD Licht \"Cancer Cell.\" 4, \"Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?\" 13 (2003)","DOI":"10.1016\/S1535-6108(03)00165-X"},{"key":"5","doi-asserted-by":"crossref","unstructured":"K Camphausen, T Scott, M Sproull, et al. \"Clin Cancer Res.\" 10, \"Enhancement of xenograft tumor radiosensitivity by the histone deacetylase inhibitor MS-275 and correlation with histone hyperacetylation.\" 6066 (2004)","DOI":"10.1158\/1078-0432.CCR-04-0537"},{"key":"6","doi-asserted-by":"crossref","unstructured":"K Camphausen, D Cerna, T Scott, et al. \"Int J Cancer.\" 114, \"Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid.\" 380 (2005)","DOI":"10.1002\/ijc.20774"},{"key":"7","doi-asserted-by":"crossref","unstructured":"K Camphausen, W Burgan, M Cerra, et al. \"Cancer Res.\" 64, \"Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275.\" 316 (2004)","DOI":"10.1158\/0008-5472.CAN-03-2630"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Y Zhang, M Jung, A Dritschilo, et al. \"Radiat Res.\" 161, \"Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors.\" 667 (2004)","DOI":"10.1667\/RR3192"},{"key":"9","doi-asserted-by":"crossref","unstructured":"P Chinnaiyan, G Vallabhaneni, E Armstrong, et al. \"Int J Radiat Oncol Biol Phys.\" 62, \"Modulation of radiation response by histone deacetylase inhibition.\" 223 (2005)","DOI":"10.1016\/j.ijrobp.2004.12.088"},{"key":"10","doi-asserted-by":"crossref","unstructured":"M Jung, A Velena, B Chen, et al. \"Radiat Res.\" 163, \"Novel HDAC inhibitors with radiosensitizing properties.\" 488 (2005)","DOI":"10.1667\/RR3345"},{"key":"11","doi-asserted-by":"crossref","unstructured":"TC Karagiannis, K Harikrishnan, A El-Osta, \"Cancer Biol Ther.\" 4, \"The histone deacetylase inhibitor, Trichostatin A, enhances radiation sensitivity and accumulation of gammaH2A. X.\" 787 (2005)","DOI":"10.4161\/cbt.4.7.1922"},{"key":"12","doi-asserted-by":"crossref","unstructured":"A Munshi, JF Kurland, T Nishikawa, et al. \"Clin Cancer Res.\" 11, \"Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.\" 4912 (2005)","DOI":"10.1158\/1078-0432.CCR-04-2088"},{"key":"13","doi-asserted-by":"crossref","unstructured":"M Yoshida, M Kijima, M Akita, et al. \"J Biol Chem.\" 265, \"Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A.\" 17174 (1990)","DOI":"10.1016\/S0021-9258(17)44885-X"},{"key":"14","doi-asserted-by":"crossref","unstructured":"M Yoshida, Y Hoshikawa, K Koseki, et al. \"J Antibiot (Tokyo).\" 43, \"Structural specificity for biological activity of trichostatin A, a specific inhibitor of mammalian cell cycle with potent differentiation-inducing activity in Friend leukemia cells.\" 1101 (1990)","DOI":"10.7164\/antibiotics.43.1101"},{"key":"15","doi-asserted-by":"crossref","unstructured":"W Wharton, J Savell, WD Cress, et al. \"J Biol Chem.\" 275, \"Inhibition of mitogenesis in Balb\/c-3T3 cells by trichostatin A multiple alterations in the inductions and activation of cyclin-cyclin-dependent kinase complexes.\" 33981 (2000)","DOI":"10.1074\/jbc.M005600200"},{"key":"16","unstructured":"DM Vigushin, S Ali, PE Pace, et al. \"Clin Cancer Res.\" 7, \"Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo.\" 971 (2001)"},{"key":"17","doi-asserted-by":"crossref","unstructured":"F Zhang, T Zhang, Z-h Teng, et al. \"Cancer Biol Ther.\" 8, \"Sensitization to gamma-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells.\" 823 (2009)","DOI":"10.4161\/cbt.8.9.8143"},{"key":"18","doi-asserted-by":"crossref","unstructured":"JH Kim, IH Kim, JH Shin, et al. \"Cancer Res Treat.\" 45, \"Sequence-dependent radiosensitization of histone deacetylase inhibitors trichostatin A and SK-7041.\" 334 (2013)","DOI":"10.4143\/crt.2013.45.4.334"},{"key":"19","doi-asserted-by":"crossref","unstructured":"M Eriksson, P Haag, B Brzozowska, et al. \"Int J Radiat Oncol Biol Phys.\" 100, \"Analysis of chromatin opening in hetero-chromatic non-small cell lung cancer tumor-initiating cells in relation to DNA-damaging antitumor treatment.\" 174 (2018)","DOI":"10.1016\/j.ijrobp.2017.09.033"},{"key":"20","doi-asserted-by":"crossref","unstructured":"L Jia, S Zhang, Y Huang, et al. \"Oncol Rep.\" 37, \"Trichostatin A increases radiosensitization of tongue squamous cell carcinoma via miR-375.\" 305 (2017)","DOI":"10.3892\/or.2016.5261"},{"key":"21","doi-asserted-by":"crossref","unstructured":"F Zhang, Z Chen, C Shao, et al. \"Mutat Res.\" 813, \"Is level of acetylation directly correlated to radiation sensitivity of cancer cell?\" 13 (2019)","DOI":"10.1016\/j.mrfmmm.2018.11.001"},{"key":"22","doi-asserted-by":"crossref","unstructured":"F Zhang, Q Huang, J Yan, et al. \"Anal Chem.\" 87, \"Assessment of the effect of trichostatin A on HeLa Cells through FT-IR spectroscopy.\" 2511 (2015)","DOI":"10.1021\/ac504691q"},{"key":"23","doi-asserted-by":"crossref","unstructured":"F Zhang, Q Huang, J Yan, et al. \"Anal Chem.\" 88, \"Histone acetylation induced transformation of B-DNA to Z-DNA in cells probed through FTIR spectroscopy.\" 4179 (2016)","DOI":"10.1021\/acs.analchem.6b00400"},{"key":"24","doi-asserted-by":"crossref","unstructured":"S Sun, Y Han, J Liu, et al. \"PloS One.\" 9, \"Trichostatin A targets the mitochondrial respiratory chain, increasing mitochondrial reactive oxygen species production to trigger apoptosis in human breast cancer cells.\" e91610 (2014)","DOI":"10.1371\/journal.pone.0091610"},{"key":"25","doi-asserted-by":"crossref","unstructured":"CP Miller, MM Singh, R-D Valle, et al. \"J Biomed Biotechnol.\" 2011, \"Therapeutic strategies to enhance the anticancer efficacy of histone deacetylase inhibitors.\" 514261 (2011)","DOI":"10.1155\/2011\/514261"},{"key":"26","doi-asserted-by":"crossref","unstructured":"AJ Frew, RW Johnstone, JE Bolden, \"Cancer letters.\" 280, \"Enhancing the apoptotic and therapeutic effects of HDAC inhibitors.\" 125 (2009)","DOI":"10.1016\/j.canlet.2009.02.042"},{"key":"28","doi-asserted-by":"crossref","unstructured":"JH Pinthus, I Bryskin, J Trachtenberg, et al. \"Neoplasia.\" 9, \"Androgen induces adaptation to oxidative stress in prostate cancer: implications for treatment with radiation therapy.\" 68 (2007)","DOI":"10.1593\/neo.06739"},{"key":"29","doi-asserted-by":"crossref","unstructured":"W Zou, C Chen, Y Zhong, et al. \"Environ Sci Technol.\" 47, \"PI3K\/Akt pathway mediates Nrf2\/ARE activation in human L02 hepatocytes exposed to low-concentration HBCDs.\" 12434 (2013)","DOI":"10.1021\/es401791s"},{"key":"30","doi-asserted-by":"crossref","unstructured":"D Martin, AI Rojo, M Salinas, et al. \"J Biol Chem.\" 279, \"Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase\/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol.\" 8919 (2004)","DOI":"10.1074\/jbc.M309660200"},{"key":"31","doi-asserted-by":"crossref","unstructured":"KC Kim, KA Kang, R Zhang, et al. \"Int J Biochem Cell Biol.\" 42, \"Up-regulation of Nrf2-mediated heme oxygenase-1 expression by eckol, a phlorotannin compound, through activation of Erk and PI3K\/Akt.\" 297 (2010)","DOI":"10.1016\/j.biocel.2009.11.009"},{"key":"32","doi-asserted-by":"crossref","unstructured":"JW Kaspar, SK Niture, AK Jaiswal, \"Free Radic Biol Med.\" 47, \"Nrf2: INrf2 (Keap1) signaling in oxidative stress.\" 1304 (2009)","DOI":"10.1016\/j.freeradbiomed.2009.07.035"},{"key":"33","doi-asserted-by":"crossref","unstructured":"R. Tyrrell, \"Antioxid Redox Signal.\" 6, \"Solar ultraviolet A radiation: an oxidizing skin carcinogen that activates heme oxygenase-1.\" 835 (2004)","DOI":"10.1089\/1523086041798033"},{"key":"34","doi-asserted-by":"crossref","unstructured":"BT Oronsky, AL Oronsky, M Lybeck, et al. \"Front Oncol.\" 5, \"Episensitization: defying time's arrow.\" 134 (2015)","DOI":"10.3389\/fonc.2015.00134"},{"key":"35","doi-asserted-by":"crossref","unstructured":"B Oronsky, N Oronsky, J Scicinski, et al. \"Transl Oncol.\" 7, \"Rewriting the epigenetic code for tumor resensitization: a review.\" 626 (2014)","DOI":"10.1016\/j.tranon.2014.08.003"},{"key":"36","doi-asserted-by":"crossref","unstructured":"B Oronsky, J Scicinski, M Kim, et al. \"Biomolecules.\" 6, \"Turning on the radio: epigenetic inhibitors as potential radiopriming agents.\" 32 (2016)","DOI":"10.3390\/biom6030032"},{"key":"37","doi-asserted-by":"crossref","unstructured":"S Biade, C Stobbe, J Boyd, et al. \"Int J Radiat Biol.\" 77, \"Chemical agents that promote chromatin compaction radiosensitize tumour cells.\" 1033 (2001)","DOI":"10.1080\/09553000110066068"},{"key":"38","doi-asserted-by":"crossref","unstructured":"JH Kim, JH Shin, IH Kim, \"Int J Radiat Oncol Biol Phys.\" 59, \"Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor.\" 1174 (2004)","DOI":"10.1016\/j.ijrobp.2004.03.001"},{"key":"39","doi-asserted-by":"crossref","unstructured":"IA Kim, JH Kim, JH Shin, et al. \"Cancer Res Treat.\" 37, \"A histone deacetylase inhibitor, trichostatin A, enhances radiosensitivity by abrogating G2\/M arrest in human carcinoma cells.\" 122 (2005)","DOI":"10.4143\/crt.2005.37.2.122"},{"key":"40","doi-asserted-by":"crossref","unstructured":"IA Kim, JH Shin, IH Kim, et al. \"Clin Cancer Res.\" 12, \"Histone deacetylase inhibitor-mediated radiosensitization of human cancer cells: Class differences and the potential influence of p53.\" 940 (2006)","DOI":"10.1158\/1078-0432.CCR-05-1230"},{"key":"41","doi-asserted-by":"crossref","unstructured":"RV Nome, A Bratland, G Harman, et al. \"Mol Cancer Ther.\" 4, \"Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death.\" 1231 (2005)","DOI":"10.1158\/1535-7163.MCT-04-0304"},{"key":"42","doi-asserted-by":"crossref","unstructured":"T Nomura, X-H Li, H Ogata, et al. \"Radiat Res.\" 176, \"Suppressive effects of continuous low-dose-rate gamma irradiation on diabetic nephropathy in type II diabetes mellitus model mice.\" 356 (2011)","DOI":"10.1667\/RR2559.1"},{"key":"43","doi-asserted-by":"crossref","unstructured":"EI. Azzam, \"Mutat Res.\" 726, \"Exposure to low level environmental agents: the induction of hormesis.\" 89 (2011)","DOI":"10.1016\/j.mrgentox.2011.07.008"},{"key":"44","doi-asserted-by":"crossref","unstructured":"MP Mattson and A Cheng \"Trends Neurosci.\" 29, \"Neurohormetic phytochemicals: low-dose toxins that induce adaptive neuronal stress responses.\" 632 (2006)","DOI":"10.1016\/j.tins.2006.09.001"},{"key":"45","doi-asserted-by":"crossref","unstructured":"J Maher and M Yamamoto \"oxicol Appl Pharmacol.\" 244, \"The rise of antioxidant signaling\u2013the evolution and hormetic actions of Nrf2.\" 4 (2010)","DOI":"10.1016\/j.taap.2010.01.011"},{"key":"46","doi-asserted-by":"crossref","unstructured":"MP Mattson, TG Son, S Camandola, \"Dose Response.\" 5, \"Mechanisms of action and therapeutic potential of neurohormetic phytochemicals.\" 174 (2007)","DOI":"10.2203\/dose-response.07-004.Mattson"},{"key":"47","doi-asserted-by":"crossref","unstructured":"DD. Zhang, \"Drug Metab Rev.\" 38, \"Mechanistic studies of the Nrf2-Keap1 signaling pathway.\" 769 (2006)","DOI":"10.1080\/03602530600971974"},{"key":"48","doi-asserted-by":"crossref","unstructured":"K Nakaso, H Yano, Y Fukuhara, et al. \"FEBS Lett.\" 546, \"PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells.\" 181 (2003)","DOI":"10.1016\/S0014-5793(03)00517-9"},{"key":"49","doi-asserted-by":"crossref","unstructured":"B D'Autreaux and MB Toledano \"Nat Rev Mol Cell Biol.\" 8, \"ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis.\" 813 (2007)","DOI":"10.1038\/nrm2256"},{"key":"50","doi-asserted-by":"crossref","unstructured":"PMD Gara, NI Garabano, MJL Portoles, et al. \"J Nanopart Res.\" 14, \"ROS enhancement by silicon nanoparticles in X-ray irradiated aqueous suspensions and in glioma C6 cells.\" 741 (2012)","DOI":"10.1007\/s11051-012-0741-8"},{"key":"51","doi-asserted-by":"crossref","unstructured":"MC Gomez-Cabrera, E Domenech, J Vina, \"Free Radic Biol Med.\" 44, \"Moderate exercise is an antioxidant: Upregulation of antioxidant genes by training.\" 126 (2008)","DOI":"10.1016\/j.freeradbiomed.2007.02.001"},{"key":"52","unstructured":"MB Irmak, G Ince, M Ozturk, et al. \"Cancer Res.\" 63, \"Acquired tolerance of hepatocellular carcinoma cells to selenium deficiency: a selective survival mechanism?\" 6707 (2003)"},{"key":"53","doi-asserted-by":"crossref","unstructured":"J-Y Je and D-B Lee \"Food Funct.\" 6, \"Nelumbo nucifera leaves protect hydrogen peroxide-induced hepatic damage via antioxidant enzymes and HO-1\/Nrf2 activation.\" 1911 (2015)","DOI":"10.1039\/C5FO00201J"},{"key":"54","doi-asserted-by":"crossref","unstructured":"X Jin, K Wang, H Liu, et al. \"Oxid Med Cell Longev.\" 2016, \"Protection of bovine mammary epithelial cells from hydrogen peroxide-induced oxidative cell damage by resveratrol.\" 1 (2016)","DOI":"10.1155\/2016\/2572175"},{"key":"55","doi-asserted-by":"crossref","unstructured":"SC. Lu, \"Curr Top Cell Regul.\" 36, \"Regulation of glutathione synthesis.\" 95 (2001)","DOI":"10.1016\/S0070-2137(01)80004-2"},{"key":"56","doi-asserted-by":"crossref","unstructured":"B Chance, H Sies, A Boveris, \"Physiol Rev.\" 59, \"Hydroperoxide metabolism in mammalian organs.\" 527 (1979)","DOI":"10.1152\/physrev.1979.59.3.527"},{"key":"57","doi-asserted-by":"crossref","unstructured":"BR You, SH Kim, WH Park, \"Tumor Biol.\" 36, \"Reactive oxygen species, glutathione, and thioredoxin influence suberoyl bishydroxamic acid-induced apoptosis in A549 lung cancer cells.\" 3429 (2015)","DOI":"10.1007\/s13277-014-2978-6"},{"key":"58","doi-asserted-by":"crossref","unstructured":"MC. Schaeffer, \"Physiol Behav.\" 40, \"Attenuation of acoustic and tactile startle responses of vitamin B-6 deficient rats.\" 473 (1987)","DOI":"10.1016\/0031-9384(87)90032-1"},{"key":"59","doi-asserted-by":"crossref","unstructured":"JL Zheng, L Zeng, MY Xu, et al. \"Fish Physiol Biochem.\" 43, \"Different effects of low- and high-dose waterborne zinc on Zn accumulation, ROS levels, oxidative damage and antioxidant responses in the liver of large yellow croaker Pseudosciaena crocea.\" 153 (2017)","DOI":"10.1007\/s10695-016-0275-6"},{"key":"60","doi-asserted-by":"crossref","unstructured":"TW Kensler, N Wakabayashi, S Biswal, \"Annu Rev Pharmacol Toxicol.\" 47, \"Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway.\" 89 (2007)","DOI":"10.1146\/annurev.pharmtox.46.120604.141046"},{"key":"61","doi-asserted-by":"crossref","unstructured":"A Loboda, M Damulewicz, E Pyza, et al. \"Cell Mol Life Sci.\" 73, \"Role of Nrf2\/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism.\" 3221 (2016)","DOI":"10.1007\/s00018-016-2223-0"},{"key":"62","doi-asserted-by":"crossref","unstructured":"E Di Gennaro, F Bruzzese, M Caraglia, et al. \"Amino Acids.\" 26, \"Acetylation of proteins as novel target for antitumor therapy: review article.\" 435 (2004)","DOI":"10.1007\/s00726-004-0087-3"},{"key":"63","doi-asserted-by":"crossref","unstructured":"KT Thurn, S Thomas, P Raha, et al. \"Mol Cancer Ther.\" 12, \"Histone deacetylase regulation of ATM-mediated DNA damage signaling.\" 2078 (2013)","DOI":"10.1158\/1535-7163.MCT-12-1242"}],"container-title":["Radiation Research"],"original-title":[],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:31:53Z","timestamp":1671755513000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/radiation-research\/volume-195\/issue-4\/RADE-20-00145.1\/Low-Dose-of-Trichostatin-A-Improves-Radiation-Resistance-by-Activating\/10.1667\/RADE-20-00145.1.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":63,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1667\/rade-20-00145.1","relation":{},"ISSN":["0033-7587"],"issn-type":[{"value":"0033-7587","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,29]]}}}